Molecular Neurobiology, 2026 Comparative Analysis of Mouse CSF Proteins in Experimental Autoimmune Encephalomyelitis Model and Cuprizone-Induced Demyelination Model by Olink Proteomics Bernaerts E., Rutten M., De Visscher A. et al. Olink Target 96 MouseNeurologyPathophysiologyMouse Csf | | | | |
GeroScience, 2026 Multiorgan transcriptomics and circulating extracellular vesicle profiling reveal age-dependent systemic vulnerability to isoflurane anesthesia and surgery Krishnamachary B., Lee H., Wang Z. et al. Olink Target 96 MouseAgingSurgical ComplicationsPathophysiologyMouse EV Lysate | | | | |
RMD Open, 2026 Cardiovascular health and osteoarthritis risk: a prospective cohort study with proteomic insights from UK Biobank Luo J., Chen X., Chen N. et al. Olink Explore 3072/384Immunological & Inflammatory DiseasesCVDPathophysiologyPlasma | | | | |
Briefings in Bioinformatics, 2026 StackAge: an ensemble-based clock for precise quantification of biological age using multi-omics data Jiang Y., Jia L., Fei Y. et al. Olink Explore 3072/384Wider Proteomics StudiesAgingPathophysiologyPlasma | | | | |
Clinical and Translational Medicine, 2026 Investigations into the aetiopathogenesis of orofacial granulomatosis using multiple omics technologies reveal a potential role for B cells Tumelty M., Patel K., Petersen H. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologySaliva | | | | |
Journal of Thrombosis and Haemostasis, 2026 Development of novel plasma proteomic biomarkers for cancer-associated thrombosis in an advanced cancer cohort Preeti P., Ranjan M., Pham D. et al. Olink Explore HTOncologyHematologyPatient StratificationPlasma | | | | |
Cardiovascular Therapeutics, 2026 Genetic Evidence Linking Inflammatory Cytokines and Blood Metabolites to Heart Failure Risk Yao Y., Tang L., Zhou P. et al. Olink Target 96CVDPathophysiologyPlasma | | | | |
European Journal of Endocrinology, 2026 Targeted Proteomics Reveals Novel Biomarkers of Disease Activity and Inflammation in Acromegaly Godang K., Wessel M., Khan Y. et al. Olink Target 96EndocrinologyPatient StratificationPlasma | | | | |
Diabetes, Obesity and Metabolism, 2026 Large‐Scale Plasma Proteomics Improves Prediction of Major Adverse Liver Outcomes in Individuals With
MASLD Yu H., Huang Y., Wang J. et al. Olink Explore 3072/384Metabolic DiseasesHepatologyPatient StratificationPlasma | | | | |
Clinica Chimica Acta, 2026 Emerging biomarkers in IgA nephropathy, membranous nephropathy, and lupus nephritis Kobayashi H., Murata Y., Akiya Y. et al. Olink FocusImmunological & Inflammatory DiseasesNephrologyPathophysiologySerum | | | | |
Journal of Extracellular Biology, 2026 Heparan Sulphate Glycosaminoglycan Chains Contribute to the Tethering of Coronal Factors and Are Important for Extracellular Vesicle‐Mediated Fibroblast Activation Veiga S., Shephard A., Milward K. et al. Olink Target 96Wider Proteomics StudiesPathophysiologyEV Lysate | | | | |
Genes & Diseases, 2026 Identification of novel therapeutic targets for heart failure and its subtypes: Insights from proteomic and transcriptomic Mendelian randomization Huang H., Ruan H., Liu J. et al. Olink Explore 3072/384CVDPathophysiologyPlasma | | | | |
Nature Communications, 2026 Multi-omics integration predicts the incidence of 17 diseases in the UK Biobank Du J., Zhou M., Wang H. et al. Olink Explore 3072/384Wider Proteomics StudiesPatient StratificationPlasma | | | | |
eBioMedicine, 2026 Influence of obesity on susceptibility to systemic symptoms and host responses to orthoflaviviral infection: a prospective observational study using yellow fever vaccine to simulate acute infection Syenina A., Tham C., Tng D. et al. Olink Target 48Metabolic DiseasesInfectious DiseasesPathophysiologyPlasma | | | | |
Phytomedicine, 2026 Combination of andrographolide and baicalin inhibited influenza A virus infection through suppressing RORγt-IL-17A pathway Cui Y., Yue Y., Lin H. et al. Olink Target 96Infectious DiseasesPathophysiologyMouse Balf | | | | |
npj Aging, 2026 Circulating levels of insulin-like growth factor binding protein 7 are associated with risks of chronic diseases and death Li Z., Tao C., Zhou Z. et al. Olink Explore 3072/384AgingPathophysiologyPlasma | | | | |
JACC: Basic to Translational Science, 2026 Mendelian Randomization Reveals Interleukin-6 Receptor-Lipoprotein(a) Interplay With Independent Cardiovascular Risk Reductions Kheirkhah A., Di Maio S., Coassin S. et al. Olink Explore 3072/384CVDPathophysiologyPlasma | | | | |
Journal of Thrombosis and Haemostasis, 2026 ADAMTS13 and von Willebrand Factor in relation to vascular cognitive impairment and cerebral small vessel disease: the heart-brain connection study Pomp A., Rosbergen M., de Maat M. et al. Olink Target 96NeurologyNeurovascular DiseasesPathophysiologySerum | | | | |
European Journal of Endocrinology, 2026 Plasma proteomic profiling identifies apolipoprotein A4 as a downregulated biomarker of adrenocortical carcinoma: a multi-platform discovery and validation study Park S., Seo H., Moon S. et al. Olink Explore 3072/384OncologyPatient StratificationCross-platform ValidationPlasma | | | | |
American Journal of Respiratory and Critical Care Medicine, 2026 Circulating Biomarker Results From a Phase 2 Study of Seralutinib in Pulmonary Arterial Hypertension Osterhout R., Boucly A., Benza R. et al. Olink Explore 3072/384CVDPathophysiologyPlasma | | | | |